The overarching aim of the Open Multiscale Systems Medicine (OpenMultiMed) COST Action is to gather a critical mass of international researchers and coordinate them as a team that develops and evaluates a transdisciplinary framework for multiscale systems medicine, consisting of novel concepts, methodologies and technologies.
“Avicenna – A Strategy for in silico Clinical Trials” was a Coordination and Support Action funded by the European Commission. Avicenna was tasked with writing a Roadmap to define the strategy for developing In Silico Clinical Trials.
The main goal of the PRIAT Project consists in the development and use of HLA peptidome analysis for the study of interpatient and intrapatient variations in the immunopeptidome in response to antibody treatment.
The PerMed consortium has 27 international partners representing key decision makers in research and research policy, industry, healthcare and patient organisations. The aim is to develop a Strategic Research and Innovation Agenda (SRIA) to foster research and implementaion of suitable Personalized Medicine (PM) approaches in Europe and beyond.
The Vistera Project aims at fostering the transition from the reactive practice of medicine to a more proactive management of health and wellness based on the principles of Systems P4 Medicine (Participatory, Personalized, Predictive and Preventive).
The Coordinating Action Systems Medicine (CASyM) will assess the basis for a European Systems Medicine paradigm and will assist the medical community in creating the foundation for a new perspective by focusing on an approach based on personalized, predictive, preventive and participatory (4P medicine).
A new working group for data processing and integration in biotechnology has been set up by the International Organization for Standardization, ISO. The working group aims to define consistent standards for the formatting, transfer and integration of life science data and models.